VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Sunday, January 11, 2026
Stock Comparison
Air Liquide S.A. vs GSK plc
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Air Liquide S.A.
AI · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Air Liquide S.A.'s moat claims, evidence, and risks.
View AI analysisGSK plc
GSK · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: GSK plc leads (62 / 100 vs 58 / 100 for Air Liquide S.A.).
- Segment focus: Air Liquide S.A. has 6 segments (44% in Industrial Merchant); GSK plc has 3 segments (37.6% in Specialty Medicines).
- Primary market structure: Competitive vs Oligopoly. Pricing power: Moderate vs Strong.
- Moat breadth: Air Liquide S.A. has 12 moat types across 3 domains; GSK plc has 4 across 3.
Primary market context
Air Liquide S.A.
Industrial Merchant
Merchant industrial and medical gases distribution (cylinders, bulk liquids) plus related equipment and services
Global (local/regional distribution markets)
SMEs and mid-market industrial customers, contractors, labs, and public sector buyers
Distributor + producer (last-mile logistics, cylinder assets, bulk delivery)
44%
GSK plc
Specialty Medicines
Branded specialty pharmaceuticals (HIV, oncology, immunology/respiratory)
Global
Hospitals, specialist physicians, payers
Innovator & branded manufacturer
37.6%
Side-by-side metrics
Moat coverage
Shared moat types
Air Liquide S.A. strengths
GSK plc strengths
Segment mix
Air Liquide S.A. segments
Full profile >Large Industries
Oligopoly
Industrial Merchant
Competitive
Healthcare
Competitive
Electronics
Oligopoly
Engineering & Construction
Competitive
Global Markets & Technologies
Competitive
GSK plc segments
Full profile >Vaccines
Oligopoly
Specialty Medicines
Oligopoly
General Medicines
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.